The published reports yelded promising results, but the interpretation of the therapeutic role of GBP in mania was difficult because the drug was already associated to a wide range of other agents, whose dose was not manteined uncharged during the study. The objective of our study was to assess the efficacy and safety of GBP versus VPA in adjunct to a fixed dose of neuroleptics (NL) in patients hospetalized because of an evidence of acute manic synptoms.
Alberti, G., Garini, R., Marzolini, M., Beltz, J., Felcher, A., Greco, M., et al. (1998). Efficacy and tolerability of gabapentin (GBP) versus valproato (VPA) as add-on therapy to neuroleptics in the treatment of acute maniac symptoms. Intervento presentato a: Congress European college of Neuropsychopharmacology.
Efficacy and tolerability of gabapentin (GBP) versus valproato (VPA) as add-on therapy to neuroleptics in the treatment of acute maniac symptoms
Felcher, A;
1998
Abstract
The published reports yelded promising results, but the interpretation of the therapeutic role of GBP in mania was difficult because the drug was already associated to a wide range of other agents, whose dose was not manteined uncharged during the study. The objective of our study was to assess the efficacy and safety of GBP versus VPA in adjunct to a fixed dose of neuroleptics (NL) in patients hospetalized because of an evidence of acute manic synptoms.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Poster1998E.pdf
accesso aperto
Descrizione: contenuto completo di poster presentato a convegno
Dimensione
265.87 kB
Formato
Adobe PDF
|
265.87 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
